Trexquant Investment LP Reduces Position in Encompass Health Corporation $EHC

Key Points

• Trexquant Investment LP has significantly reduced its stake in Encompass Health Corporation by 79.9% during the first quarter, now holding only 8,438 shares valued at $855,000.
• Encompass Health recently reported a quarterly earnings per share (EPS) of $1.40, exceeding analyst expectations of $1.20 and up from $1.11 during the same period last year.
• The company has announced an increase in its quarterly dividend to $0.19 per share, up from $0.17, with a scheduled payment date of October 15th.

Trexquant Investment LP lessened its holdings in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 79.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,438 shares of the company's stock after selling 33,630 shares during the period. Trexquant Investment LP's holdings in Encompass Health were worth $855,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. OneDigital Investment Advisors LLC purchased a new stake in Encompass Health during the 1st quarter valued at about $263,000. GAMMA Investing LLC raised its stake in Encompass Health by 21.5% during the first quarter. GAMMA Investing LLC now owns 2,366 shares of the company's stock worth $240,000 after purchasing an additional 419 shares during the period. Sequoia Financial Advisors LLC boosted its holdings in Encompass Health by 6.7% in the 1st quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company's stock valued at $276,000 after purchasing an additional 172 shares during the last quarter. Cambridge Investment Research Advisors Inc. boosted its holdings in Encompass Health by 30.1% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 9,597 shares of the company's stock valued at $972,000 after purchasing an additional 2,218 shares during the last quarter. Finally, Fifth Third Bancorp boosted its holdings in Encompass Health by 88.7% in the 1st quarter. Fifth Third Bancorp now owns 4,290 shares of the company's stock valued at $434,000 after purchasing an additional 2,017 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on EHC shares. KeyCorp boosted their target price on shares of Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a report on Tuesday, May 27th. Wall Street Zen lowered shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a report on Friday, June 6th. UBS Group boosted their target price on shares of Encompass Health from $130.00 to $140.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Truist Financial boosted their target price on shares of Encompass Health from $135.00 to $140.00 and gave the company a "buy" rating in a report on Thursday, August 14th. Finally, Stephens upgraded shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 target price on the stock in a report on Thursday, June 5th. One research analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Buy" and a consensus price target of $134.00.

Insider Transactions at Encompass Health

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the sale, the executive vice president directly owned 18,846 shares in the company, valued at $2,329,177.14. This represents a 5.13% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 2.10% of the stock is currently owned by company insiders.

Encompass Health Stock Performance

Shares of EHC stock opened at $125.59 on Monday. The firm's 50 day moving average price is $116.93 and its 200-day moving average price is $112.01. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. Encompass Health Corporation has a one year low of $87.85 and a one year high of $125.86. The firm has a market cap of $12.65 billion, a P/E ratio of 24.58, a P/E/G ratio of 2.20 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last released its earnings results on Monday, August 4th. The company reported $1.40 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.20 by $0.20. The company had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The firm's quarterly revenue was up 12.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.11 EPS. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. As a group, equities research analysts predict that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a dividend of $0.19 per share. This is a boost from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date is Wednesday, October 1st. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. Encompass Health's dividend payout ratio (DPR) is currently 13.31%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.